|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
| Market Cap | 39Cr 11Cr 9.29Cr 8.56Cr 8.01Cr 15Cr 1.02TCr 15Cr 101.09Cr 497.65Cr 40Cr 40Cr 1.72TCr | P/E Ratio 2025 |
-9.3x | P/E Ratio 2026 * | -7.23x |
|---|---|---|---|---|---|
| Enterprise Value | 29Cr 7.84Cr 6.77Cr 6.24Cr 5.84Cr 11Cr 744.85Cr 11Cr 74Cr 362.55Cr 29Cr 29Cr 1.26TCr | EV / Sales 2025 |
4,315x | EV / Sales 2026 * | 119x |
| Free-Float |
77.15% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +1.47% | ||
| 1 week | +1.30% | ||
| Current month | +6.69% | ||
| 1 month | +8.36% | ||
| 3 months | -11.14% | ||
| 6 months | -13.37% | ||
| Current year | -8.66% |
| 1 week | 120.4 |  | 125 |
| 1 month | 109 | | 125.8 |
| Current year | 109 | | 159.2 |
| 1 year | 109 | | 182.2 |
| 3 years | 109 | | 239 |
| 5 years | 83 | | 348 |
| 10 years | 9.55 | | 348 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcin Izydorzak
PRN | Corporate Officer/Principal | 52 | - |
Piotr Garstecki
CEO | Chief Executive Officer | 50 | - |
Szymon Ruta
DFI | Director of Finance/CFO | 50 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 07/03/2017 | |
| Director/Board Member | 50 | 07/03/2017 | |
| Director/Board Member | 63 | 07/03/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/01 | Sell | Chairman | 36,000 | 1.1363% | ||
| 15/01 | Buy | Chairman | 36,000 | 1.1363% | ||
| 15/01 | Others | Chairman | 1,40,000 | 4.4188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | +1.30% | -17.40% | -37.80% | 11Cr | |
| -0.19% | -2.87% | +77.33% | +76.87% | 377.66Cr | |
| -6.03% | +4.14% | +69.07% | +121.66% | 281.68Cr | |
| +4.05% | -2.03% | -33.07% | -39.21% | 194.05Cr | |
| +3.03% | -3.55% | +76.62% | -51.94% | 182.17Cr | |
| -2.92% | +3.24% | +21.99% | +176.75% | 118.66Cr | |
| -0.36% | -6.03% | -16.02% | +17.61% | 85Cr | |
| -0.72% | -22.50% | +101.17% | - | 78Cr | |
| -4.41% | -0.80% | +120.35% | -64.81% | 73Cr | |
| +0.66% | -4.95% | -31.11% | -16.90% | 54Cr | |
| Average | -0.54% | -0.90% | +36.89% | +20.25% | 145.59Cr | |
| Weighted average by Cap. | -0.78% | -0.53% | +49.68% | +45.45% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 7L 2L 2L 2L 1L 3L 1.82Cr 3L 17.95L 88.39L 7L 7L 3.06Cr | 25L 7L 6L 5L 5L 10L 6.49Cr 10L 64.12L 3.16Cr 25.61L 25.06L 11Cr |
| Net income | -3.93Cr -1.07Cr -92.64L -85.37L -79.91L -1.5Cr -101.95Cr -1.52Cr -10Cr -50Cr -4.03Cr -3.94Cr -171.82Cr | -5.44Cr -1.48Cr -1.28Cr -1.18Cr -1.11Cr -2.07Cr -141.12Cr -2.1Cr -14Cr -69Cr -5.57Cr -5.45Cr -237.83Cr |
| Net Debt | -11Cr -2.92Cr -2.52Cr -2.32Cr -2.18Cr -4.08Cr -277.57Cr -4.14Cr -27Cr -135.1Cr -11Cr -11Cr -467.79Cr | -9.71Cr -2.65Cr -2.29Cr -2.11Cr -1.97Cr -3.7Cr -251.89Cr -3.76Cr -25Cr -122.6Cr -9.95Cr -9.73Cr -424.51Cr |
Employees
157
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 124.40 zł | +1.47% | 677 |
| 11/26/11 | 122.60 zł | -1.61% | 376 |
| 10/26/10 | 124.60 zł | -0.32% | 575 |
| 09/26/09 | 125.00 zł | +0.32% | 1,079 |
| 08/26/08 | 124.60 zł | +1.47% | 2,365 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
124.40PLN
Average target price
198.20PLN
Spread / Average Target
+59.32%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCP Stock
Select your edition
All financial news and data tailored to specific country editions
